Skip to main content
. 2022 Sep 12;2022:8559176. doi: 10.1155/2022/8559176

Table 6.

Analysis of peripheral serum hormone, vasomotor factor and immune function in patients with menopausal syndrome.

Index Numer of studies Study ID (Author, year) Cases of experimental group Cases of control group MD [95%CI] Z value P value
LH 2 Zhou 2015
Han and Wan 2020
152 153 −6.94 [−10.93, −2.96] 3.41 0.0006
FSH 2 Zhou 2015
Han and Wan 2020
152 153 −9.59 [−18.44, −0.73] 2.12 0.03
E2 2 Zhou 2015
Han and Wan 2020
152 153 56.53 [−23.99, 137.05] 1.38 0.17
T 1 Zhou 2015 86 86 9.49 [9.40, 9.57] 216.7 <0.00001
PRL 1 Zhou 2015 86 86 −0.22 [−28.10, 27.66] 0.02 0.99
NE 1 Han and Wan 2020 66 67 23.42 [17.79, 29.05] 8.16 <0.00001
5-HT 1 Han and Wan 2020 66 67 0.71 [0.58, 0.84] 11.12 <0.00001
NO 1 Han and Wan 2020 66 67 9.29 [−140.61, 159.19] 0.12 0.9
ET-1 1 Han and Wan 2020 66 67 −8.13 [−10.51, −5.75] 6.69 <0.00001
CGRP 1 Han and Wan 2020 66 67 −5.20 [−6.42, −3.98] 8.39 <0.00001
CD-3 2 Shen 2019
Zhou 2015
136 136 6.11 [5.35, 6.86] 15.92 <0.00001
CD-4 2 Shen 2019
Zhou 2015
136 136 7.36 [6.43, 8.28] 15.59 <0.00001
CD-8 2 Shen 2019
Zhou 2015
136 136 −5.59 [−6.80, −4.37] 9.02 <0.00001
IL-2 2 Shen 2019
Zhou 2015
136 136 10.39 [5.76, 15.01] 4.4 <0.0001